Status:
RECRUITING
The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases
Lead Sponsor:
Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia
Conditions:
Chronic Venous Diseases
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Investigation of the influence of combined oral contraception on the development and progression of chronic venous diseases
Eligibility Criteria
Inclusion
- The investigators consistently include patients who have been prescribed hormonal tablets for contraception, namely 1) COCs with bioidentical estrogen; 2) COCs with ethinyl estradiol 30mkg according to the scheme 21 + 7; 3) COCs with ethinyl estradiol 20mkg according to the scheme 21 + 7.
- Clinical class C0-1 according to CEAP;
- 2\) Able to come for checkups every 3 months; 3) The presence of informed consent.
Exclusion
- Age up to 45 years;
- A history of surgical treatment of veins of the lower extremities;
- Clinical class C2 and higher according to CEAP;
- History of DVT or PE;
- Aplasia or angio-dysplasia of deep veins;
- Restriction of mobility;
- Arterial insufficiency;
- Oncological diseases.
Key Trial Info
Start Date :
June 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 24 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04451746
Start Date
June 24 2020
End Date
August 24 2025
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic of phlebology and laser surgery
Chelyabinsk, Russia, 454090